Iktos
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
65 Rue De Prony, Paris, Ile-de-France, 7...Phone Number
+33 973584548Website
www.iktos.aiRevenue
$19.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Iktos
Incorporated in October 2016, Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existing data, to design molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as professional services and as a SaaS software platform, Makya. Iktos is also developing Spaya, a synthesis planning software based upon Iktos's proprietary AI technology for retrosynthesis. Iktos has recently diversified its R&D efforts into the development of an AI technology for peptide-based therapeutics and has developed state-of-the-art generative and predictive models to facilitate deRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Iktos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Iktos launches new products
Website visits: Recent activity has been detected on your website
Check out if Iktos is spiking on competitors!
Iktos, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Iktos has new funding data
Earning: See what the market has to say on Iktos recently announced quarterly report
Click to see if Iktos had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Iktos has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Iktos
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Iktos is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Iktos is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Iktos.
Iktos financials insights
Gather financial insights about Iktos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$16.4M
2025
Grant
$2.6M
Iktos Tech Stack
A closer look at the technologies used by Iktos
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Person-Based
Funding
Funding
Iktos News & Media
Iktos hires tech industry veteran Dr Ashiq H Khan as Chief Business Officer to drive Global Growth & Pharma Partnerships
PARIS, FRANCE, September 3, 2025 /EINPresswire.com/ -- Iktos, a global leader in AI-driven drug discovery, today announced the appointment of Dr. Ashiq H. Khan as Chief Business Officer (CBO) to spearhead the company’s global commercial expansion in AI- …Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery
PARIS, Feb. 20, 2025 /PRNewswire/ -- Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology. This funding, with the potential for...Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration
Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to develop novel agonists of the Amylin Receptor PARIS and MONHEIM, Germany, Jan. 10, 2025 /PRNewswire/ -- Iktos, a leader in Artificial Intelligence (AI) and Robotics for...Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies
Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Iktos
Sign Up For FreeTo access detailed company insights
Incorporated in October 2016, Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existin... Read More
